印度是Eli Lilly与Novo Nordisk之间全球竞争中的关键, India is key in global race between Eli Lilly and Novo Nordisk for weight-loss drug dominance.

印度正在成为Eli Lilly和Novo Nordisk之间全球竞争争夺权重损失毒品市场支配地位的关键战场,两家公司都在肥胖率上升和对有效治疗的需求增加的情况下扩大该国的临床试验和营销工作。 India is emerging as a critical battleground in the global competition between Eli Lilly and Novo Nordisk for dominance in the weight-loss drug market, with both companies expanding clinical trials and marketing efforts in the country amid rising obesity rates and growing demand for effective treatments.